TSE:APH - Aphria Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$15.15 -0.55 (-3.50 %) (As of 11/21/2018 07:34 AM ET)Previous CloseC$15.70Today's RangeC$14.65 - C$16.6452-Week RangeC$7.51 - C$24.75Volume12.85 million shsAverage Volume6.58 million shsMarket CapitalizationN/AP/E Ratio84.17Dividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada. Receive APH News and Ratings via Email Sign-up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange TSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolTSE:APH Previous Symbol CUSIPN/A Webwww.aphria.com Phone844-427-4742 Debt Debt-to-Equity Ratio2.65 Current Ratio4.44 Quick Ratio2.74 Price-To-Earnings Trailing P/E Ratio84.17 Forward P/E Ratio29.71 P/E GrowthN/A Sales & Book Value Annual SalesC$36.92 million Price / SalesN/A Cash FlowC$0.45 per share Price / Cash33.59 Book ValueC$5.54 per share Price / Book2.74 Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees300 Outstanding SharesN/AMarket CapC$0.00 OptionableOptionable Aphria (TSE:APH) Frequently Asked Questions What is Aphria's stock symbol? Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APH." How were Aphria's earnings last quarter? Aphria Inc (TSE:APH) announced its earnings results on Friday, October, 12th. The company reported $0.09 EPS for the quarter, topping the Zacks' consensus estimate of ($0.06) by $0.15. The firm earned $13.29 million during the quarter, compared to the consensus estimate of $13.15 million. View Aphria's Earnings History. When is Aphria's next earnings date? Aphria is scheduled to release their next quarterly earnings announcement on Wednesday, January 9th 2019. View Earnings Estimates for Aphria. What price target have analysts set for APH? 1 analysts have issued 12 month price targets for Aphria's stock. Their forecasts range from C$24.50 to C$31.00. On average, they anticipate Aphria's share price to reach C$26.83 in the next year. This suggests a possible upside of 77.1% from the stock's current price. View Analyst Price Targets for Aphria. What is the consensus analysts' recommendation for Aphria? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aphria. Has Aphria been receiving favorable news coverage? Headlines about APH stock have been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Aphria earned a news impact score of -1.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days. Who are some of Aphria's key competitors? Some companies that are related to Aphria include Acerus Pharmaceuticals (ASP), Aequus Pharmaceuticals (AQS), Amryt Pharma (AMYT), Aurora Cannabis (ACB), Bausch Health Companies (BHC), Benchmark (BMK), Biosyent (RX), Cannabis Science (CBIS), Canopy Growth (WEED), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF), Cipher Pharmaceuticals (CPH), Cosmos (COSM) and CV Sciences (CVSI). Who are Aphria's key executives? Aphria's management team includes the folowing people: Mr. Victor Neufeld, Chair of the Board of Directors, CEO & Pres (Age 64)Mr. Cole Cacciavillani, Co-Founder, VP of Growing Operations & Director (Age 63)Mr. John Cervini, Co-Founder, VP of Infrastructure & Technology and Director (Age 48)Mr. Carl A. Merton, Chief Financial OfficerMs. Megan McCrae, Director of Marketing How do I buy shares of Aphria? Shares of APH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Aphria's stock price today? One share of APH stock can currently be purchased for approximately C$15.15. What is Aphria's official website? The official website for Aphria is http://www.aphria.com/. How can I contact Aphria? Aphria's mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company can be reached via phone at 844-427-4742. MarketBeat Community Rating for Aphria (TSE APH)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 270 (Vote Outperform)Underperform Votes: 250 (Vote Underperform)Total Votes: 520MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe APH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/21/2018 by MarketBeat.com StaffFeatured Article: What is the NASDAQ?